Rebel Medicine Inc is a science-led pharmaceutical company based in Salt Lake City, Utah, focused on healthcare and therapeutic development.
Subscribe to see Rebel Medicine Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rebel Medicine Inc is a company headquartered in United States. It has raised at least $14.8M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $6M in June 2025. Xcout tracks 6 named people at Rebel Medicine Inc, including Brett Davis (Chief Executive Officer).
At least $14.8M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $6M | 7 named | |
| SEC Form D filing | $8.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Rebel Medicine Inc's closest competitors — see the full list of competitors and alternatives →
Receptor Life Sciences, Inc. is a pharmaceutical company based in Seattle, Washington, that applies innovative technologies to develop therapeutic products.
Revalesio Corp is a pharmaceutical and biotechnology company headquartered in Tacoma, Washington, and incorporated in Delaware. The company focuses on the research, development, and clinical pipeline of novel therapeutic drug candidates.
Remedy Pharmaceuticals, Inc. is a late-stage specialty pharmaceutical company located in New York City focused on therapies capable of transforming treatments.
CenExel Clinical Research is a leading clinical trial site network headquartered in Salt Lake City, Utah. The organization partners with progressive life science companies to deliver high-quality clinical research across various therapeutic areas.
Vira Regen Inc. is a biotechnology research company based in Salt Lake City, Utah, focused on regenerative medicine via electrogenetics.
Curza, Inc., based in Salt Lake City, Utah, is a life sciences company developing a pipeline of next-generation therapeutics. The company works to address critical global health challenges, such as the antimicrobial resistance (AMR) crisis.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.